scPharmaceuticals Inc.
SCPHDelisted Oct 7, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001604950
scPharmaceuticals Inc. was delisted on Oct 7, 2025; its insiders filed their last Form 4 on Oct 7, 2025; 110 institutions reported holding it in 13F filings for Q3 2025, worth $232.3M in total; no superinvestor held it.
13F holders, Q2 2021
Institutional positions in scPharmaceuticals Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 38
- −8 vs. Q1 2021
- Shares held
- 16.0M
- −1.12M (−6.6%) vs. Q1 2021
- Total value
- $97.9M
- −$16.1M (−14.1%) vs. Q1 2021
- New holders
- 5
- 4 more added
- Sold out
- 13
- 23 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SCPH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 110 | $232.3M |
| Q2 2025 | 98 | $145.7M |
| Q1 2025 | 88 | $98.7M |
| Q4 2024 | 86 | $140.8M |
| Q3 2024 | 95 | $169.8M |
| Q2 2024 | 77 | $121.0M |
| Q1 2024 | 76 | $134.2M |
| Q4 2023 | 81 | $175.4M |
| Q3 2023 | 73 | $213.1M |
| Q2 2023 | 81 | $290.8M |
| Q1 2023 | 63 | $223.2M |
| Q4 2022 | 59 | $153.5M |
| Q3 2022 | 40 | $91.3M |
| Q2 2022 | 38 | $75.9M |
| Q1 2022 | 37 | $90.1M |
| Q4 2021 | 33 | $80.0M |
| Q3 2021 | 31 | $107.9M |
| Q2 2021 | 38 | $97.9M |
| Q1 2021 | 46 | $114.1M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding scPharmaceuticals Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| New York State Common Retirement Fund | 50 | $0 | 0.00% | −6,850−99.3% | Reduced |
| Wells Fargo & Company | 60 | $0 | 0.00% | −2,136−97.3% | Reduced |
| Captrust Financial Advisors | 39 | $0 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 259 | $1.58K | 0.00% | −568−68.7% | Reduced |
| Advisor Group Holdings, Inc. | 357 | $2.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 704 | $4.00K | 0.00% | −1,680−70.5% | Reduced |
| Barclays PLC | 770 | $5.00K | 0.00% | −5,079−86.8% | Reduced |
| Royal Bank of Canada | 874 | $5.00K | 0.00% | +33+3.9% | Added |
| Bank of America Corp | 1,493 | $9.00K | 0.00% | −6,771−81.9% | Reduced |
| Tower Research Capital LLC (TRC) | 2,112 | $13.0K | 0.00% | −621−22.7% | Reduced |
| JPMorgan Chase & Co | 3,174 | $19.0K | 0.00% | −15,856−83.3% | Reduced |
| Two Sigma Advisers, LP | 11,000 | $67.0K | 0.00% | −700−6.0% | Reduced |
| HRT Financial LP | 20,261 | $123.0K | 0.00% | +20,261 | New |
| First Trust Advisors LP | 23,614 | $144.0K | 0.00% | −823−3.4% | Reduced |
| Ergoteles LLC | 27,872 | $170.0K | 0.00% | +27,872 | New |
| Bank of New York Mellon Corp | 34,643 | $211.0K | 0.00% | −12,034−25.8% | Reduced |
| Zacks Investment Management | 36,989 | $226.0K | 0.00% | +36,989 | New |
| DAFNA Capital Management LLC | 38,891 | $238.0K | 0.05% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 44,827 | $273.0K | 0.00% | −2,051−4.4% | Reduced |
| Northern Trust Corp | 49,885 | $305.0K | 0.00% | −64,988−56.6% | Reduced |
| Millennium Management LLC | 57,717 | $353.0K | 0.00% | +57,717 | New |
| Morgan Stanley | 61,164 | $374.0K | 0.00% | +6,875+12.7% | Added |
| BlackRock Inc. | 62,197 | $380.0K | 0.00% | −266,972−81.1% | Reduced |
| Geode Capital Management, LLC | 66,475 | $406.0K | 0.00% | −31,605−32.2% | Reduced |
| Bridgeway Capital Management, LLC | 102,200 | $624.0K | 0.01% | −500−0.5% | Reduced |
| Goldman Sachs Group Inc | 115,264 | $704.0K | 0.00% | −533,506−82.2% | Reduced |
| Boothbay Fund Management, LLC | 124,827 | $763.0K | 0.03% | −9,689−7.2% | Reduced |
| Jacobs Levy Equity Management, Inc | 138,604 | $847.0K | 0.01% | −2,363−1.7% | Reduced |
| Worth Venture Partners, LLC | 163,994 | $1.00M | 0.37% | −50,066−23.4% | Reduced |
| Russell Investments Group, Ltd. | 194,238 | $1.19M | 0.00% | +194,238 | New |
| Renaissance Technologies LLC | 216,486 | $1.32M | 0.00% | +25,100+13.1% | Added |
| Vanguard Group Inc | 608,948 | $3.72M | 0.00% | −34,507−5.4% | Reduced |
| AIGH Capital Management LLC | 642,154 | $3.92M | 1.06% | −212,988−24.9% | Reduced |
| J. Goldman & Co LP | 720,877 | $4.41M | 0.28% | +522,451+263.3% | Added |
| Ikarian Capital, LLC | 1,095,024 | $6.69M | 1.20% | −213,675−16.3% | Reduced |
| Ra Capital Management, L.P. | 2,731,170 | $16.7M | 0.27% | 00.0% | Unchanged |
| 5AM Venture Management, LLC | 3,831,474 | $23.4M | 5.89% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 4,797,148 | $29.3M | 0.30% | 00.0% | Unchanged |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −355,690−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −104,119−100.0% | Sold out |
| Nuveen Asset Management, LLC | 0 | $0 | 0.00% | −32,739−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −14,397−100.0% | Sold out |
| Invesco Ltd. | 0 | $0 | 0.00% | −10,726−100.0% | Sold out |
| California State Teachers Retirement System | 0 | $0 | 0.00% | −10,596−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −4,495−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −4,079−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −827−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −465−100.0% | Sold out |
| Panagora Asset Management Inc | 0 | $0 | 0.00% | −470−100.0% | Sold out |
| Ameritas Investment Partners, Inc. | 0 | $0 | 0.00% | −475−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −261−100.0% | Sold out |